BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.692
-0.498 (-41.82%)
At close: Dec 20, 2024, 4:00 PM
0.730
+0.038 (5.45%)
After-hours: Dec 20, 2024, 7:45 PM EST
BioAtla Stock Forecast
BCAB's stock price has decreased by -65.39% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioAtla stock has a target of 5.00, which predicts an increase of 622.23% from the current stock price of 0.69.
Analyst Consensus: Buy
* Price targets were last updated on Sep 16, 2024.
Analyst Ratings
The average analyst rating for BioAtla stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +622.23% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $12 → $5 | Buy | Maintains | $12 → $5 | +622.23% | May 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +911.12% | May 15, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +1,633.35% | Mar 28, 2024 |
Financial Forecast
Revenue This Year
11.22M
Revenue Next Year
n/a
from 11.22M
EPS This Year
-1.55
from -2.58
EPS Next Year
-1.34
from -1.55
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 11.6M | n/a | n/a | |||
| Avg | 11.2M | n/a | n/a | |||
| Low | 10.8M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.53 | -1.07 | -0.85 | |||
| Avg | -1.55 | -1.34 | -1.36 | |||
| Low | -1.58 | -1.48 | -1.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.